Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: May 2013
-
McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar entitled "Preventing Chinese Trade Secret Theft: The Obama Administration's Strategy on Mitigating the Theft of U.S. Trade Secrets" on June 11, 2013 from 10:00 am to 11:15 am (CT). MBHB attorney Joshua Rich will cover recent developments in the attempt to mitigate theft…
-
By Kevin E. Noonan — Enactment of the Leahy-Smith America Invents Act in 2011 focused the patenting community on the changes of U.S. patent law from "first to invent" under the 1952 Patent Act to "first inventor to file" under the AIA as the basis for deciding priority and defining the scope of prior art…
-
By Andrew Williams — On May 20, 2013, the Supreme Court granted certiorari in the Medtronic Inc. v. Boston Scientific Corp. case (Supreme Court docket number 12-1128). The sole issue on appeal is encapsulated by the question presented: QUESTION PRESENTED: In Medlmmune, Inc. v. Genentech, Inc., 549 U.S. 118, 137 (2007), this Court ruled that a…
-
By Michael Borella — A previous post presented the background of this case, as well as Judge Lourie's plurality concurrence, and a second post addressed Chief Judge Rader's concurrence-in-part and dissent-in-part. As noted in those posts, Alice's claimed inventions involved the reduction of settlement risk using a third-party intermediary. This post continues the story of…
-
By Michael Borella — A previous post presented the background of this case, as well as Judge Lourie's plurality concurrence. As noted in that post, Alice's claimed inventions involved the reduction of settlement risk using a third-party intermediary. Despite the claims being of various statutory classes, including process, article of manufacture, and machine, Judge Lourie…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. AbbVie Inc. v. Hetero USA Inc. et al.1:13-cv-00852; filed May 15, 2013 in the District Court of Delaware • Plaintiff: AbbVie Inc.• Defendants: Hetero USA Inc.; Hetero Labs Ltd. Infringement of U.S. Patent Nos. 7,148,359…
-
May 21, 2013 – Ethics in IP Practice (Intellectual Property Law Association of Chicago) – Chicago, IL May 21-23, 2013 – Pharma Legal Affairs (IBC Life Sciences) – Shanghai, China May 27, 2013 – A Harmonized Patent World — Are We Getting There? (Intellectual Property Owners Association) – Brussels, Belgium May 29, 2013 – AIA…
-
The Chisum Patent Academy will be offering its next Advanced Patent Law Seminars from July 31 to August 2, 2013 and from August 5-7, 2013 in Seattle, WA. The three-day seminar will focus on the following patent law topics: • Patent Practice Gone Wrong: Lessons from Recent Cases on Patent Malpractice and Rule 11 Sanctions•…
-
The Intellectual Property Law Association of Chicago (IPLAC) will be offering a program on "Ethics in IP Practice" on May 21, 2013 from 12:00 to 5:00 pm (Central) at the offices of Winston & Strawn LLP in Chicago, IL. Wendy Muchman, Chief of Litigation/Professional Education, ARDC; Michael Barrett, Director of Risk Control, CNA; and William…
-
By Donald Zuhn — In March, the World Intellectual Property Organization (WIPO) announced that International patent applications filed under the Patent Cooperation Treaty (PCT) increased by 6.6% in 2012. WIPO noted that of the 194,000 PCT applications filed last year, Japan and U.S. accounted for nearly half (48.8%) of those applications. Five countries had double-digit…
Patent Docs 